Drug Profile
Cytomegalovirus vaccine live - Xenova
Latest Information Update: 30 May 2002
Price :
$50
*
At a glance
- Originator Xenova Group
- Class Cytomegalovirus vaccines; Viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections
Most Recent Events
- 26 May 2002 Discontinued - Preclinical for Cytomegalovirus infections in United Kingdom (unspecified route)
- 26 Jun 2001 No-Development-Reported for Cytomegalovirus infections in United Kingdom (Unknown route)
- 30 Aug 1996 New profile